Kun Peng

Kun Peng

Auto-generated profile, based on publicly available information

Kun Peng

MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti‐Infective Drug Development, IGCME, GBRCE for Functional Molecular Engineering School of Chemistry Sun Yat‐Sen University Guangzhou 510006 China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2023 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
KPKun Peng
Kun Peng
YZYue Zheng
Yue Zheng
wei xiawei xia
wei xia
ZMZong-Wan Mao
Zong-Wan Mao
Organometallics act through specific biomolecular targets or tumor homeostasis perturbation to induce various cell death pathways.

23 November 2021 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
MGMaria Gil‐Moles
Maria Gil‐Moles
STSebastian Türck
Sebastian Türck
UBUttara Basu
Uttara Basu
APAndrea Pettenuzzo
Andrea Pettenuzzo
SBSaurav Bhattacharya
Saurav Bhattacharya
IOIngo Ott
Ingo Ott
The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS‐CoV‐2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain‐like protease PLpro. In addition to many well‐established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal‐based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS‐CoV‐2 assays confirming activity for gold complexes with N‐heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal‐based SARS‐CoV‐2 antiviral agents.

6 June 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
YZYue Zheng
Yue Zheng
XCXiao-Xiao Chen
Xiao-Xiao Chen
DZDong-Yang Zhang
Dong-Yang Zhang
WWWen-Jin Wang
Wen-Jin Wang
KPKun Peng
Kun Peng
CTCai-Ping Tan
Cai-Ping Tan
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon (STING) pathway is a key mediator of innate immunity involved in cancer development and treatment. The roles of mitochondrial DNA (mtDNA) in cancer immunotherapy have gradually emerged. Herein, we report a highly emissive rhodium(III) complex (Rh-Mito) as the mtDNA intercalator. Rh-Mito can specifically bind to mtDNA to cause the cytoplasmic release of mtDNA fragments to activate the cGAS-STING pathway. Moreover, Rh-Mito activates the mitochondrial retrograde signaling by disturbing the key metabolites involved in epigenetic modifications, which alters the nuclear genome methylation landscape to influence the expression of genes related to immune signaling pathways. Finally, we demonstrate that ferritin-encapsulated Rh-Mito elicits potent anticancer activities and evokes intense immune responses in vivo by intravenous injection. Overall, we report for the first time that small molecules targeting mtDNA can activate the cGAS-STING pathway, which gives insights into the development of biomacromolecule-targeted immunotherapeutic agents.

2 June 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
YZYue Zheng
Yue Zheng
KPKun Peng
Kun Peng
QCQian Cao
Qian Cao
ZMZong-Wan Mao
Zong-Wan Mao

1 June 2010
Verified
Conference Paper
Closed access
XYXianghua Ying
Xianghua Ying
KPKun Peng
Kun Peng
RRRen Ren
Ren Ren
HZHongbin Zha
Hongbin Zha
A catadioptric system consisting of a pinhole camera and two planar mirrors is deeply investigated in this paper. The two mirrors combine to form a corner and face-to-face with the pinhole. Their relative pose is unknown. An object will be reflected in the mirror corner one-time or multiple-times. Using the pinhole, we may take an image containing the object and its reflections, i.e., simultaneously imaging multiple views of an object by a single camera. We discovered that each 3D point and its reflections lie on a circle. We call the point set composed of a 3D point and its reflections, a Reflection Point Group (RPG), and the circle related to a RPG is called a RPG circle. All RPG circles are parallel to one another. Furthermore, each RPG can be partitioned into two separate subgroups. Shape formed by all points in a subgroup is invariant with respect to location of the 3D point. From these geometric properties, two calibration approaches can be utilized: One is based on parallel circles; the other is using 2D homographies among invariant shapes. Experiments validate our approaches.

8 June 2022 in Aging
Verified
Journal Article
Open access
PDF file
JZJinpeng Zhang
Jinpeng Zhang
XDXiaohui Ding
Xiaohui Ding
KPKun Peng
Kun Peng
ZJZhankui Jia
Zhankui Jia
JYJinjian Yang
Jinjian Yang
Background: Immunotherapy has a significant effect on the treatment of many tumor types. However, prostate cancers generally fail to show significant responses to immunotherapy owing to their immunosuppressive microenvironments. To sustain progress towards more effective immunotherapy for prostate cancer, comprehensive analyses of the genetic characteristics of the immune microenvironment and novel therapeutic strategies are required. Methods: The transcriptome profiles of patients with prostate cancer were obtained from GEO and processed with the TIDE algorithm to predict their responses to immunotherapy. Next, the significant differentially expressed genes (DEGs) between the responder and non-responder groups were identified and used to compute the co-expression modules by WGCNA. Then, co-expression networks were constructed and survival analysis was applied to hub genes. Finally, drug candidates to alleviate immunosuppression were filtered in prostate cancer using GSEA based on hub genes. Results: In total, we identified 2758 significant DEGs and constructed 16 co-expression modules, seven of which were significantly correlated with the immune response score. In total, 133 hub genes were identified, of which 13 were significantly associated with prostate cancer prognosis. Co-expression networks of hub genes were constructed with KMT2B at the center. Finally, six candidate drugs for prostate cancer immunotherapy were identified in PC3 and LNCaP cell lines. Conclusions: We obtained datasets from multiple platforms, performed integrated bioinformatic analysis to identify 133 hub genes and 13 biomarkers of an immunotherapy response, and six candidate drugs were filtered to inhibit the immunosuppressive tumor microenvironment, to ultimately improve patient responses to immunotherapy in prostate cancer.